CUSIP 49721T507COMKPRXQ4 2025
13 filings · latest Jan 29, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Adar1 Capital Management, LLC | 167.9K | $330.8K |
| 2 | Stonepine Capital Management, LLC | 131.1K | $258.4K |
| 3 | Drw Securities, LLC | 110.3K | $217.3K |
| 4 | Nantahala Capital Management, LLC | 106.2K | $209.1K |
| 5 | Alyeska Investment Group, L.P. | 76.9K | $151.5K |
| 6 | Vanguard Group Inc | 33.1K | $65.2K |
| 7 | Citadel Advisors LLC | 22.4K | $44.1K |
| 8 | Geode Capital Management, LLC | 22.0K | $43.4K |
| 9 |
| 4 | Aug 14, 2025 | Nantahala Capital Partners Limited Partnership | 13G | 5.3% | 189.7K | SEC |
| 5 | Feb 14, 2025 | Alyeska Investment Group, L.P. | 13G/A | 2.5% | 75.6K | SEC |
| 6 | Feb 12, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 130 | SEC |
| 7 | Feb 10, 2025 | Orin Hirschman | 13G/A | 8.5% | 255.56B | SEC |
| 8 | Nov 14, 2024 | Alyeska Investment Group, L.P. | 13G | 8.4% | 256.4K | SEC |
| 9 | Nov 14, 2024 | Nantahala Capital Management, LLC | 13G | 10.0% | 306.3K | SEC |
| 10 | Nov 14, 2024 | Adar1 Capital Management, LLC | 13G | 10.0% | 310.8K | SEC |
See the full Schedule 13D/13G history for Kiora Pharmaceuticals Inc.
Unlock full history| Renaissance Technologies LLC |
| 21.2K |
| $41.8K |
| 10 | Xtx Topco Ltd | 12.0K | $23.6K |